Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesImproving Health R&D Financing For Developing Countries: A Menu Of Innovative Policy Options
Health Affairs, 07/16/09
Hecht R et al. - New approaches are needed to generate more resources, make funding more stable and flexible, and further engage the expertise of the pharmaceutical industry. Several new financing mechanisms have been launched recently, and others are being proposed. This paper summarizes some of the most promising new ideas and offers a framework for evaluating them.
Related Articles
Economic Evaluation and Cost-Effectiveness Thresholds: Signals to Firms and Implications for R&D Investment and Innovation
PharmacoEconomics, 10/07/09
Relevance Score: 89%
Faiz Kermani The rise of in silico R&D
Pharmaceutical Technology, 10/14/09
Relevance Score: 84%
Cephalon, Inc. to Webcast R&D Day
Cephalon, 11/05/09
Relevance Score: 80%
Cerner Enters R&D Pact with University
HealthDataManagement, 10/06/09
Relevance Score: 80%
Novartis delivers strong new product momentum and operational performance in first nine months of 2009
Novartis, 10/23/09
Relevance Score: 77%
Today in Economics of Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Utilization and Expenditures on Chiropractic Care in the United States from 1997 to 2006
Health Services Research, 12/08/09
Private costs almost equal health care costs when intervening in mild Alzheimers
BMC Health Services Research, 12/07/09
Hospitals and communities continue to feel recession's impact
American Hospital Association News, 12/04/09
Sponsor
Article Search
Sponsor